Table of Contents Author Guidelines Submit a Manuscript
Stem Cells International
Volume 2016, Article ID 3162743, 10 pages
http://dx.doi.org/10.1155/2016/3162743
Review Article

Mesenchymal Stem Cells Regulate the Innate and Adaptive Immune Responses Dampening Arthritis Progression

1Laboratorio de Inmunología Celular y Molecular, Centro de Investigación Biomédica, Facultad de Medicina, Universidad de los Andes, Santiago, Chile
2Programa Doctorado en Biomedicina, Facultad de Medicina, Universidad de los Andes, Santiago, Chile
3Inserm, U 1183, 34091 Montpellier, France
4Université de Montpellier, 34000 Montpellier, France

Received 6 August 2016; Accepted 3 October 2016

Academic Editor: Fernando Ezquer

Copyright © 2016 R. A. Contreras et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. D. Isaacs, “The changing face of rheumatoid arthritis: sustained remission for all?” Nature Reviews Immunology, vol. 10, no. 8, pp. 605–611, 2010. View at Publisher · View at Google Scholar
  2. I. B. McInnes and G. Schett, “The pathogenesis of rheumatoid arthritis,” The New England Journal of Medicine, vol. 365, no. 23, pp. 2205–2219, 2011. View at Publisher · View at Google Scholar
  3. V. Majithia and S. A. Geraci, “Rheumatoid arthritis: diagnosis and management,” The American Journal of Medicine, vol. 120, no. 11, pp. 936–939, 2007. View at Publisher · View at Google Scholar
  4. J. S. Smolen, D. Aletaha, and K. Redlich, “The pathogenesis of rheumatoid arthritis: new insights from old clinical data?” Nature Reviews Rheumatology, vol. 8, no. 4, pp. 235–243, 2012. View at Publisher · View at Google Scholar
  5. A. Calabro, A. L. Caterino, E. Elefante et al., “One year in review 2016: novelties in the treatment of rheumatoid arthritis,” Clinical and Experimental Rheumatology, vol. 34, no. 3, pp. 357–372, 2016. View at Google Scholar
  6. Y. Tanaka, “Human mesenchymal stem cells as a tool for joint repair in rheumatoid arthritis,” Clinical and Experimental Rheumatology, vol. 33, no. 4, supplement 92, pp. S58–S62, 2015. View at Google Scholar
  7. K. Le Blanc and M. F. Pittenger, “Mesenchymal stem cells: progress toward promise,” Cytotherapy, vol. 7, no. 1, pp. 36–45, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Dominici, K. Le Blanc, I. Mueller et al., “Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement,” Cytotherapy, vol. 8, no. 4, pp. 315–317, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. Y. A. Romanov, A. N. Darevskaya, N. V. Merzlikina, and L. B. Buravkova, “Mesenchymal stem cells from human bone marrow and adipose tissue: isolation, characterization, and differentiation potentialities,” Bulletin of Experimental Biology and Medicine, vol. 140, no. 1, pp. 138–143, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. F. Alcayaga-Miranda, J. Cuenca, P. Luz-Crawford et al., “Characterization of menstrual stem cells: angiogenic effect, migration and hematopoietic stem cell support in comparison with bone marrow mesenchymal stem cells,” Stem Cell Research and Therapy, vol. 6, article 32, 2015. View at Publisher · View at Google Scholar · View at Scopus
  11. P. L. González, C. Carvajal, J. Cuenca et al., “Chorion mesenchymal stem cells show superior differentiation, immunosuppressive, and angiogenic potentials in comparison with haploidentical maternal placental cells,” Stem Cells Translational Medicine, vol. 4, no. 10, pp. 1109–1121, 2015. View at Publisher · View at Google Scholar · View at Scopus
  12. T. I. Mitrano, M. S. Grob, F. Carrion et al., “Culture and characterization of mesenchymal stem cells from human gingival tissue,” Journal of Periodontology, vol. 81, no. 6, pp. 917–925, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. U. Galderisi and A. Giordano, “The gap between the physiological and therapeutic roles of mesenchymal stem cells,” Medicinal Research Reviews, vol. 34, no. 5, pp. 1100–1126, 2014. View at Publisher · View at Google Scholar
  14. P. R. Crisostomo, Y. Wang, T. A. Markel, M. Wang, T. Lahm, and D. R. Meldrum, “Human mesenchymal stem cells stimulated by TNF-α, LPS, or hypoxia produce growth factors by an NFκB-but not JNK-dependent mechanism,” American Journal of Physiology-Cell Physiology, vol. 294, no. 3, pp. C675–C682, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Aggarwal and M. F. Pittenger, “Human mesenchymal stem cells modulate allogeneic immune cell responses,” Blood, vol. 105, no. 4, pp. 1815–1822, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. G. M. Spaggiari, A. Capobianco, H. Abdelrazik, F. Becchetti, M. C. Mingari, and L. Moretta, “Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production: role of indoleamine 2,3-dioxygenase and prostaglandin E2,” Blood, vol. 111, no. 3, pp. 1327–1333, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. P. Luz-Crawford, M. Kurte, J. Bravo-Alegría et al., “Mesenchymal stem cells generate a CD4+CD25+Foxp3+ regulatory T cell population during the differentiation process of Th1 and Th17 cells,” Stem Cell Research & Therapy, vol. 4, no. 3, article 65, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. P. Luz-Crawford, F. Djouad, K. Toupet et al., “Mesenchymal stem cell-derived interleukin 1 receptor antagonist promotes macrophage polarization and inhibits B cell differentiation,” STEM CELLS, vol. 34, no. 2, pp. 483–492, 2016. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Ghannam, C. Bouffi, F. Djouad, C. Jorgensen, and D. Noël, “Immunosuppression by mesenchymal stem cells: mechanisms and clinical applications,” Stem Cell Research & Therapy, vol. 1, no. 1, article 2, 2010. View at Publisher · View at Google Scholar
  20. E. Zappia, S. Casazza, E. Pedemonte et al., “Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy,” Blood, vol. 106, no. 5, pp. 1755–1761, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Ji, Q. Guo, Y. Han, G. Tan, Y. Luo, and F. Zeng, “Mesenchymal stem cell transplantation inhibits abnormal activation of Akt/GSK3β signaling pathway in T cells from systemic lupus erythematosus mice,” Cellular Physiology and Biochemistry, vol. 29, no. 5-6, pp. 705–712, 2012. View at Publisher · View at Google Scholar
  22. M. Ohshima, K. Yamahara, S. Ishikane et al., “Systemic transplantation of allogenic fetal membrane-derived mesenchymal stem cells suppresses Th1 and Th17 T cell responses in experimental autoimmune myocarditis,” Journal of Molecular and Cellular Cardiology, vol. 53, no. 3, pp. 420–428, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. M. A. González, E. Gonzalez-Rey, L. Rico, D. Büscher, and M. Delgado, “Treatment of experimental arthritis by inducing immune tolerance with human adipose-derived mesenchymal stem cells,” Arthritis & Rheumatism, vol. 60, no. 4, pp. 1006–1019, 2009. View at Publisher · View at Google Scholar
  24. M. Chen, W. Su, X. Lin et al., “Adoptive transfer of human gingiva-derived mesenchymal stem cells ameliorates collagen-induced arthritis via suppression of Th1 and Th17 cells and enhancement of regulatory T cell differentiation,” Arthritis and Rheumatism, vol. 65, no. 5, pp. 1181–1193, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. C. Bouffi, C. Bony, G. Courties, C. Jorgensen, D. Noël, and S. Agarwal, “IL-6-dependent PGE2 secretion by mesenchymal stem cells inhibits local inflammation in experimental arthritis,” PLoS ONE, vol. 5, no. 12, Article ID e14247, 2010. View at Publisher · View at Google Scholar
  26. P. Luz-Crawford, M. J. Torres, D. Noël et al., “The immunosuppressive signature of menstrual blood mesenchymal stem cells entails opposite effects on experimental arthritis and graft versus host diseases,” Stem Cells, vol. 34, no. 2, pp. 456–469, 2016. View at Publisher · View at Google Scholar · View at Scopus
  27. C. Sullivan, J. M. Murphy, M. D. Griffin et al., “Genetic mismatch affects the immunosuppressive properties of mesenchymal stem cells in vitro and their ability to influence the course of collagen-induced arthritis,” Arthritis Research & Therapy, vol. 14, no. 4, article R167, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. J. M. Lee, J. Jung, H.-J. Lee et al., “Comparison of immunomodulatory effects of placenta mesenchymal stem cells with bone marrow and adipose mesenchymal stem cells,” International Immunopharmacology, vol. 13, no. 2, pp. 219–224, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. I. A. Udalova, A. Mantovani, and M. Feldmann, “Macrophage heterogeneity in the context of rheumatoid arthritis,” Nature Reviews Rheumatology, vol. 12, no. 8, pp. 472–485, 2016. View at Publisher · View at Google Scholar
  30. R. D. Stout, “Functional plasticity of macrophages: reversible adaptation to changing microenvironments,” Journal of Leukocyte Biology, vol. 76, no. 3, pp. 509–513, 2004. View at Publisher · View at Google Scholar
  31. A. A. Tarique, J. Logan, E. Thomas, P. G. Holt, P. D. Sly, and E. Fantino, “Phenotypic, functional, and plasticity features of classical and alternatively activated human macrophages,” American Journal of Respiratory Cell and Molecular Biology, vol. 53, no. 5, pp. 676–688, 2015. View at Publisher · View at Google Scholar · View at Scopus
  32. K. Takasugi and J. W. Hollingsworth, “Morphologic studies of mononuclear cells of human synovial fluid,” Arthritis and Rheumatism, vol. 10, no. 6, pp. 495–501, 1967. View at Publisher · View at Google Scholar · View at Scopus
  33. G. Janossy, G. Panayi, O. Duke, M. Bofill, L. W. Poulter, and G. Goldstein, “Rheumatoid arthritis: a disease of T-lymphocyte/macrophage immunoregulation,” The Lancet, vol. 318, no. 8251, pp. 839–842, 1981. View at Publisher · View at Google Scholar · View at Scopus
  34. A. Kennedy, U. Fearon, D. J. Veale, and C. Godson, “Macrophages in synovial inflammation,” Frontiers in Immunology, vol. 2, article 52, 2011. View at Publisher · View at Google Scholar
  35. L. Ye, Z. Wen, Y. Li et al., “Interleukin-10 attenuation of collagen-induced arthritis is associated with suppression of interleukin-17 and retinoid-related orphan receptor γt production in macrophages and repression of classically activated macrophages,” Arthritis Research & Therapy, vol. 16, no. 2, article R96, 2014. View at Publisher · View at Google Scholar
  36. O. A. Hamilton, E. L. Filonzi, and G. Ianches, “Regulation of macrophage colony-stimulating factor (m-CSF) production in cultured human synovial fibroblasts,” Growth Factors, vol. 9, no. 2, pp. 157–165, 1993. View at Publisher · View at Google Scholar · View at Scopus
  37. Y. Shigeyama, T. Pap, P. Kunzler, B. R. Simmen, R. E. Gay, and S. Gay, “Expression of osteoclast differentiation factor in rheumatoid arthritis,” Arthritis and Rheumatism, vol. 43, no. 11, pp. 2523–2530, 2000. View at Publisher · View at Google Scholar · View at Scopus
  38. S. L. Teitelbaum, “Osteoclasts, integrins, and osteoporosis,” Journal of Bone and Mineral Metabolism, vol. 18, no. 6, pp. 344–349, 2000. View at Publisher · View at Google Scholar · View at Scopus
  39. S. Kotake, T. Yago, M. Kawamoto, and Y. Nanke, “Role of osteoclasts and interleukin-17 in the pathogenesis of rheumatoid arthritis: crucial ‘human osteoclastology’,” Journal of Bone and Mineral Metabolism, vol. 30, no. 2, pp. 125–135, 2012. View at Publisher · View at Google Scholar · View at Scopus
  40. G. Schett and S. L. Teitelbaum, “Osteoclasts and arthritis,” Journal of Bone and Mineral Research, vol. 24, no. 7, pp. 1142–1146, 2009. View at Publisher · View at Google Scholar
  41. M. G. Garimella, S. Kour, V. Piprode et al., “Adipose-derived mesenchymal stem cells prevent systemic bone loss in collagen-induced arthritis,” The Journal of Immunology, vol. 195, no. 11, pp. 5136–5148, 2015. View at Publisher · View at Google Scholar
  42. M. H. Abumaree, M. A. Al Jumah, B. Kalionis et al., “Human placental mesenchymal stem cells (pMSCs) play a role as immune suppressive cells by shifting macrophage differentiation from inflammatory M1 to anti-inflammatory M2 macrophages,” Stem Cell Reviews and Reports, vol. 9, no. 5, pp. 620–641, 2013. View at Publisher · View at Google Scholar · View at Scopus
  43. A. Uccelli and N. K. de Rosbo, “The immunomodulatory function of mesenchymal stem cells: mode of action and pathways,” Annals of the New York Academy of Sciences, vol. 1351, no. 1, pp. 114–126, 2015. View at Publisher · View at Google Scholar
  44. H. Choi, R. H. Lee, N. Bazhanov, J. Y. Oh, and D. J. Prockop, “Anti-inflammatory protein TSG-6 secreted by activated MSCs attenuates zymosan-induced mouse peritonitis by decreasing TLR2/NF-κB signaling in resident macrophages,” Blood, vol. 118, no. 2, pp. 330–338, 2011. View at Publisher · View at Google Scholar
  45. L. A. Ortiz, M. Dutreil, C. Fattman et al., “Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injury,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 26, pp. 11002–11007, 2007. View at Publisher · View at Google Scholar · View at Scopus
  46. A. K. Abbas and A. H. Sharpe, “Dendritic cells giveth and taketh away,” Nature Immunology, vol. 6, no. 3, pp. 227–228, 2005. View at Publisher · View at Google Scholar · View at Scopus
  47. S. V. Sennikov, S. A. Falaleeva, N. S. Shkaruba et al., “Maturation and cytokine production potential of dendritic cells isolated from rheumatoid arthritis patients peripheral blood and induced in vitro,” Human Immunology, vol. 77, no. 10, pp. 930–936, 2016. View at Publisher · View at Google Scholar
  48. S. H. Byun, J. H. Lee, N. C. Jung et al., “Rosiglitazone-mediated dendritic cells ameliorate collagen-induced arthritis in mice,” Biochemical Pharmacology, vol. 115, pp. 85–93, 2016. View at Publisher · View at Google Scholar
  49. X.-X. Jiang, Y. Zhang, B. Liu et al., “Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells,” Blood, vol. 105, no. 10, pp. 4120–4126, 2005. View at Publisher · View at Google Scholar · View at Scopus
  50. H. Li, Z. Guo, X. Jiang, H. Zhu, X. Li, and N. Mao, “Mesenchymal stem cells alter migratory property of T and dendritic cells to delay the development of murine lethal acute graft-versus-host disease,” STEM CELLS, vol. 26, no. 10, pp. 2531–2541, 2008. View at Publisher · View at Google Scholar · View at Scopus
  51. S. Chiesa, S. Morbelli, S. Morando et al., “Mesenchymal stem cells impair in vivo T-cell priming by dendritic cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 42, pp. 17384–17389, 2011. View at Publisher · View at Google Scholar · View at Scopus
  52. F. Djouad, L.-M. Charbonnier, C. Bouffi et al., “Mesenchymal stem cells inhibit the differentiation of dendritic cells through an interleukin-6-dependent mechanism,” Stem Cells, vol. 25, no. 8, pp. 2025–2032, 2007. View at Publisher · View at Google Scholar · View at Scopus
  53. L. A. Fogel, W. M. Yokoyama, and A. R. French, “Natural killer cells in human autoimmune disorders,” Arthritis Research & Therapy, vol. 15, no. 4, p. 216, 2013. View at Publisher · View at Google Scholar
  54. K. Soderstrom, E. Stein, P. Colmenero et al., “Natural killer cells trigger osteoclastogenesis and bone destruction in arthritis,” Proceedings of the National Academy of Sciences, vol. 107, no. 29, pp. 13028–13033, 2010. View at Publisher · View at Google Scholar
  55. C. K. Lo, Q. L. Lam, L. Sun et al., “Natural killer cell degeneration exacerbates experimental arthritis in mice via enhanced interleukin-17 production,” Arthritis & Rheumatism, vol. 58, no. 9, pp. 2700–2711, 2008. View at Publisher · View at Google Scholar
  56. Y. Yanagihara, K. Shiozawa, M. Takai, M. Kyogoku, and S. Shiozawa, “Natural killer (NK) T cells are significantly decreased in the peripheral blood of patients with rheumatoid arthritis (RA),” Clinical and Experimental Immunology, vol. 118, no. 1, pp. 131–136, 1999. View at Publisher · View at Google Scholar · View at Scopus
  57. L. Moretta and A. Moretta, “Unravelling natural killer cell function: triggering and inhibitory human NK receptors,” The EMBO Journal, vol. 23, no. 2, pp. 255–259, 2004. View at Publisher · View at Google Scholar
  58. C. Almeida, H. Caires, D. Vasconcelos, and M. Barbosa, “NAP-2 secreted by human NK cells can stimulate mesenchymal stem/stromal cell recruitment,” Stem Cell Reports, vol. 6, no. 4, pp. 466–473, 2016. View at Publisher · View at Google Scholar
  59. G. M. Spaggiari, A. Capobianco, S. Becchetti, M. C. Mingari, and L. Moretta, “Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation,” Blood, vol. 107, no. 4, pp. 1484–1490, 2006. View at Publisher · View at Google Scholar · View at Scopus
  60. C. Noone, A. Kihm, K. English, S. O'Dea, and B. P. Mahon, “IFN-γ stimulated human umbilical-tissue-derived cells potently suppress NK activation and resist NK-mediated cytotoxicity in vitro,” Stem Cells and Development, vol. 22, no. 22, pp. 3003–3014, 2013. View at Publisher · View at Google Scholar
  61. L. Klareskog, K. Amara, and V. Malmström, “Adaptive immunity in rheumatoid arthritis,” Current Opinion in Rheumatology, vol. 26, no. 1, pp. 72–79, 2014. View at Publisher · View at Google Scholar
  62. K. M. Hamel, Y. Cao, S. A. Olalekan, and A. Finnegan, “B cell-specific expression of inducible costimulator ligand is necessary for the induction of arthritis in mice,” Arthritis and Rheumatology, vol. 66, no. 1, pp. 60–67, 2014. View at Publisher · View at Google Scholar · View at Scopus
  63. F. E. Lund and T. D. Randall, “Effector and regulatory B cells: modulators of CD4+ T cell immunity,” Nature Reviews Immunology, vol. 10, no. 4, pp. 236–247, 2010. View at Publisher · View at Google Scholar
  64. E. Traggiai, S. Volpi, F. Schena et al., “Bone marrow-derived mesenchymal stem cells induce both polyclonal expansion and differentiation of B cells isolated from healthy donors and systemic lupus erythematosus patients,” STEM CELLS, vol. 26, no. 2, pp. 562–569, 2008. View at Publisher · View at Google Scholar · View at Scopus
  65. M. M. Rosado, M. E. Bernardo, M. Scarsella et al., “Inhibition of B-cell proliferation and antibody production by mesenchymal stromal cells is mediated by T cells,” Stem Cells and Development, vol. 24, no. 1, pp. 93–103, 2015. View at Publisher · View at Google Scholar
  66. F. Schena, C. Gambini, A. Gregorio et al., “Interferon-gamma-dependent inhibition of B cell activation by bone marrow-derived mesenchymal stem cells in a murine model of systemic lupus erythematosus,” Arthritis and Rheumatism, vol. 62, no. 9, pp. 2776–2786, 2010. View at Google Scholar · View at Scopus
  67. S. Asari, S. Itakura, K. Ferreri et al., “Mesenchymal stem cells suppress B-cell terminal differentiation,” Experimental Hematology, vol. 37, no. 5, pp. 604–615, 2009. View at Publisher · View at Google Scholar
  68. N. Che, X. Li, L. Zhang et al., “Impaired B cell inhibition by lupus bone marrow mesenchymal stem cells is caused by reduced CCl2 expression,” The Journal of Immunology, vol. 193, no. 10, pp. 5306–5314, 2014. View at Publisher · View at Google Scholar · View at Scopus
  69. M. E. Healy, R. Bergin, B. P. Mahon, and K. English, “Mesenchymal stromal cells protect against caspase 3-mediated apoptosis of CD19+ peripheral B cells through contact-dependent upregulation of VEGF,” Stem Cells and Development, vol. 24, no. 20, pp. 2391–2402, 2015. View at Publisher · View at Google Scholar · View at Scopus
  70. M. Franquesa, F. K. Mensah, R. Huizinga et al., “Human adipose tissue-derived mesenchymal stem cells abrogate plasmablast formation and induce regulatory B cells independently of T helper cells,” Stem Cells, vol. 33, no. 3, pp. 880–891, 2014. View at Publisher · View at Google Scholar · View at Scopus
  71. Y. Qin, Z. Zhou, F. Zhang et al., “Induction of regulatory B-cells by mesenchymal stem cells is affected by SDF-1a-CXCR7,” Cellular Physiology and Biochemistry, vol. 37, no. 1, pp. 117–130, 2015. View at Publisher · View at Google Scholar
  72. J. A. Van Boxel and S. A. Paget, “Predominantly T-cell infiltrate in rheumatoid synovial membranes,” The New England Journal of Medicine, vol. 293, no. 11, pp. 517–520, 1975. View at Publisher · View at Google Scholar
  73. A. N. Abdel-Nour, C. J. Elson, and P. A. Dieppe, “Proliferative responses of T-cell lines grown from joint fluids of patients with rheumatoid arthritis and other arthritides,” Immunology Letters, vol. 12, no. 5-6, pp. 329–333, 1986. View at Publisher · View at Google Scholar · View at Scopus
  74. D. M. Gravano and K. K. Hoyer, “Promotion and prevention of autoimmune disease by CD8+ T cells,” Journal of Autoimmunity, vol. 45, pp. 68–79, 2013. View at Publisher · View at Google Scholar · View at Scopus
  75. V. Taneja, N. Taneja, T. Paisansinsup et al., “CD4 and CD8 T cells in susceptibility/protection to collagen-induced arthritis in HLA-DQ8-transgenic mice: implications for rheumatoid arthritis,” The Journal of Immunology, vol. 168, no. 11, pp. 5867–5875, 2002. View at Publisher · View at Google Scholar · View at Scopus
  76. A. Petrelli and F. van Wijk, “CD8+ T cells in human autoimmune arthritis: the unusual suspects,” Nature Reviews Rheumatology, vol. 12, no. 7, pp. 421–428, 2016. View at Publisher · View at Google Scholar
  77. A. U. Engela, C. C. Baan, N. H. Litjens et al., “Mesenchymal stem cells control alloreactive CD8(+) CD28(−) T cells,” Clinical & Experimental Immunology, vol. 174, no. 3, pp. 449–458, 2013. View at Publisher · View at Google Scholar
  78. Q. Liu, H. Zheng, X. Chen et al., “Human mesenchymal stromal cells enhance the immunomodulatory function of CD8+CD28 regulatory T cells,” Cellular and Molecular Immunology, vol. 12, no. 6, pp. 708–718, 2014. View at Publisher · View at Google Scholar
  79. B. Homey, “After TH1/TH2 now comes Treg/TH17: significance of T helper cells in immune response organization,” Hautarzt, vol. 57, no. 8, pp. 730–732, 2006. View at Publisher · View at Google Scholar
  80. R. V. Luckheeram, R. Zhou, A. D. Verma, and B. Xia, “CD4+ T cells: differentiation and functions,” Clinical and Developmental Immunology, vol. 2012, Article ID 925135, 12 pages, 2012. View at Publisher · View at Google Scholar
  81. I. I. Ivanov, B. S. McKenzie, L. Zhou et al., “The orphan nuclear receptor RORγt directs the differentiation program of proinflammatory IL-17+ T helper cells,” Cell, vol. 126, no. 6, pp. 1121–1133, 2006. View at Publisher · View at Google Scholar · View at Scopus
  82. F. Annunziato, L. Cosmi, V. Santarlasci et al., “Phenotypic and functional features of human Th17 cells,” The Journal of Experimental Medicine, vol. 204, no. 8, pp. 1849–1861, 2007. View at Publisher · View at Google Scholar
  83. A. K. Simon, E. Seipelt, and J. Sieper, “Divergent T-cell cytokine patterns in inflammatory arthritis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 91, no. 18, pp. 8562–8566, 1994. View at Publisher · View at Google Scholar · View at Scopus
  84. Y. Morita, M. Yamamura, M. Kawashima et al., “Flow cytometric single-cell analysis of cytokine production by CD4+ T cells in synovial tissue and peripheral blood from patients with rheumatoid arthritis,” Arthritis and Rheumatism, vol. 41, no. 9, pp. 1669–1676, 1998. View at Publisher · View at Google Scholar · View at Scopus
  85. A. M. Malfait, D. M. Butler, D. H. Presky, R. N. Maini, F. M. Brennan, and M. Feldmann, “Blockade of IL-12 during the induction of collagen-induced arthritis (CIA) markedly attenuates the severity of the arthritis,” Clinical and Experimental Immunology, vol. 111, no. 2, pp. 377–383, 1998. View at Publisher · View at Google Scholar · View at Scopus
  86. C. A. Murphy, C. L. Langrish, Y. Chen et al., “Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation,” The Journal of Experimental Medicine, vol. 198, no. 12, pp. 1951–1957, 2003. View at Publisher · View at Google Scholar
  87. B. Oppmann, R. Lesley, B. Blom et al., “Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12,” Immunity, vol. 13, no. 5, pp. 715–725, 2000. View at Publisher · View at Google Scholar · View at Scopus
  88. K. Vermeire, H. Heremans, M. Vandeputte, S. Huang, A. Billiau, and P. Matthys, “Accelerated collagen-induced arthritis in IFN-γ receptor-deficient mice,” Journal of Immunology, vol. 158, no. 11, pp. 5507–5513, 1997. View at Google Scholar · View at Scopus
  89. S. Sarkar, L. A. Cooney, P. White et al., “Regulation of pathogenic IL-17 responses in collagen-induced arthritis: roles of endogenous interferon-gamma and IL-4,” Arthritis Research & Therapy, vol. 11, no. 5, article R158, 2009. View at Publisher · View at Google Scholar
  90. E. Lubberts, “Role of T lymphocytes in the development of rheumatoid arthritis. Implications for treatment,” Current Pharmaceutical Design, vol. 21, no. 2, pp. 142–146, 2015. View at Google Scholar · View at Scopus
  91. E. Bettelli, Y. Carrier, W. Gao et al., “Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells,” Nature, vol. 441, no. 7090, pp. 235–238, 2006. View at Publisher · View at Google Scholar · View at Scopus
  92. S. Sakaguchi, M. Ono, R. Setoguchi et al., “Foxp3+CD25+CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease,” Immunological Reviews, vol. 212, pp. 8–27, 2006. View at Publisher · View at Google Scholar · View at Scopus
  93. E. M. Shevach, “Mechanisms of Foxp3+ T regulatory cell-mediated suppression,” Immunity, vol. 30, no. 5, pp. 636–645, 2009. View at Publisher · View at Google Scholar
  94. J. H. Buckner, “Mechanisms of impaired regulation by CD4+CD25+FOXP3+ regulatory T cells in human autoimmune diseases,” Nature Reviews Immunology, vol. 10, no. 12, pp. 849–859, 2010. View at Publisher · View at Google Scholar
  95. Q. Niu, B. Cai, Z. C. Huang, Y. Y. Shi, and L. L. Wang, “Disturbed Th17/Treg balance in patients with rheumatoid arthritis,” Rheumatology International, vol. 32, no. 9, pp. 2731–2736, 2012. View at Publisher · View at Google Scholar
  96. M. R. Ehrenstein, J. G. Evans, A. Singh et al., “Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFα therapy,” The Journal of Experimental Medicine, vol. 200, no. 3, pp. 277–285, 2004. View at Publisher · View at Google Scholar
  97. M. D. Nicola, C. Carlo-Stella, M. Magni et al., “Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli,” Blood, vol. 99, no. 10, pp. 3838–3843, 2002. View at Publisher · View at Google Scholar · View at Scopus
  98. R. Tatara, K. Ozaki, Y. Kikuchi et al., “Mesenchymal stromal cells inhibit Th17 but not regulatory T-cell differentiation,” Cytotherapy, vol. 13, no. 6, pp. 686–694, 2011. View at Publisher · View at Google Scholar · View at Scopus
  99. K. English, J. M. Ryan, L. Tobin, M. J. Murphy, F. P. Barry, and B. P. Mahon, “Cell contact, prostaglandin E2 and transforming growth factor beta 1 play non-redundant roles in human mesenchymal stem cell induction of CD4+CD25Highforkhead box P3+ regulatory T cells,” Clinical and Experimental Immunology, vol. 156, no. 1, pp. 149–160, 2009. View at Publisher · View at Google Scholar · View at Scopus
  100. S. Ghannam, J. Pène, G. Torcy-Moquet, C. Jorgensen, and H. Yssel, “Mesenchymal stem cells inhibit human Th17 cell differentiation and function and induce a T regulatory cell phenotype,” Journal of Immunology, vol. 185, no. 1, pp. 302–312, 2010. View at Publisher · View at Google Scholar · View at Scopus
  101. P. Luz-Crawford, D. Noël, X. Fernandez et al., “Mesenchymal stem cells repress Th17 molecular program through the PD-1 pathway,” PLoS ONE, vol. 7, no. 9, Article ID e45272, 2012. View at Publisher · View at Google Scholar · View at Scopus
  102. M. M. Duffy, J. Pindjakova, S. A. Hanley et al., “Mesenchymal stem cell inhibition of T-helper 17 cell- differentiation is triggered by cell-cell contact and mediated by prostaglandin E2 via the EP4 receptor,” European Journal of Immunology, vol. 41, no. 10, pp. 2840–2851, 2011. View at Publisher · View at Google Scholar · View at Scopus
  103. N. Obermajer, F. C. Popp, Y. Soeder, J. Haarer, E. K. Geissler, H. J. Schlitt et al., “Conversion of Th17 into IL-17Aneg regulatory T cells: a novel mechanism in prolonged allograft survival promoted by mesenchymal stem cell-supported minimized immunosuppressive therapy,” Journal of Immunology, vol. 193, no. 10, pp. 4988–4999, 2014. View at Publisher · View at Google Scholar
  104. S. Selleri, M. M. Dieng, S. Nicoletti et al., “Cord-blood-derived mesenchymal stromal cells downmodulate CD4+ T-cell activation by inducing il-10-producing th1 cells,” Stem Cells and Development, vol. 22, no. 7, pp. 1063–1075, 2013. View at Publisher · View at Google Scholar · View at Scopus
  105. Y. H. Chao, H. P. Wu, K. H. Wu et al., “An increase in CD3+CD4+CD25+ regulatory T cells after administration of umbilical cord-derived mesenchymal stem cells during sepsis,” PLoS ONE, vol. 9, no. 10, Article ID e110338, 2014. View at Publisher · View at Google Scholar
  106. P. Luz-Crawford, G. Tejedor, A. L. Mausset-Bonnefont et al., “Glucocorticoid-induced leucine zipper governs the therapeutic potential of mesenchymal stem cells by inducing a switch from pathogenic to regulatory Th17 cells in a mouse model of collagen-induced arthritis,” Arthritis and Rheumatology, vol. 67, no. 6, pp. 1514–1524, 2015. View at Publisher · View at Google Scholar · View at Scopus
  107. M. Krampera, L. Cosmi, R. Angeli et al., “Role for interferon-γ in the immunomodulatory activity of human bone marrow mesenchymal stem cells,” STEM CELLS, vol. 24, no. 2, pp. 386–398, 2006. View at Publisher · View at Google Scholar · View at Scopus
  108. F. Liotta, R. Angeli, L. Cosmi et al., “Toll-like receptors 3 and 4 are expressed by human bone marrow-derived mesenchymal stem cells and can inhibit their T-cell modulatory activity by impairing notch signaling,” Stem Cells, vol. 26, no. 1, pp. 279–289, 2008. View at Publisher · View at Google Scholar · View at Scopus
  109. G. Ren, L. Zhang, X. Zhao et al., “Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide,” Cell Stem Cell, vol. 2, no. 2, pp. 141–150, 2008. View at Publisher · View at Google Scholar · View at Scopus
  110. G. Ren, X. Zhao, L. Zhang et al., “Inflammatory cytokine-induced intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in mesenchymal stem cells are critical for immunosuppression,” The Journal of Immunology, vol. 184, no. 5, pp. 2321–2328, 2010. View at Publisher · View at Google Scholar
  111. J. Croitoru-Lamoury, F. M. J. Lamoury, M. Caristo et al., “Interferon-γ regulates the proliferation and differentiation of mesenchymal stem cells via activation of indoleamine 2,3 dioxygenase (IDO),” PLoS ONE, vol. 6, no. 2, Article ID e14698, 2011. View at Publisher · View at Google Scholar · View at Scopus
  112. A. Dorronsoro, I. Ferrin, J. M. Salcedo et al., “Human mesenchymal stromal cells modulate T-cell responses through TNF-α-mediated activation of NF-κB,” European Journal of Immunology, vol. 44, no. 2, pp. 480–488, 2014. View at Publisher · View at Google Scholar
  113. K. Kemp, E. Gray, E. Mallam, N. Scolding, and A. Wilkins, “Inflammatory cytokine induced regulation of superoxide dismutase 3 expression by human mesenchymal stem cells,” Stem Cell Reviews and Reports, vol. 6, no. 4, pp. 548–559, 2010. View at Publisher · View at Google Scholar · View at Scopus
  114. M. Krampera, “Mesenchymal stromal cell ‘licensing’: a multistep process,” Leukemia, vol. 25, no. 9, pp. 1408–1414, 2011. View at Publisher · View at Google Scholar · View at Scopus
  115. J. Croitoru-Lamoury, F. M. Lamoury, J. J. Zaunders, L. A. Veas, and B. J. Brew, “Human mesenchymal stem cells constitutively express chemokines and chemokine receptors that can be upregulated by cytokines, IFN-β, and Copaxone,” Journal of Interferon & Cytokine Research, vol. 27, no. 1, pp. 53–64, 2007. View at Publisher · View at Google Scholar
  116. X.-X. He, H. Bai, G.-R. Yang, Y.-J. Xue, and Y.-N. Su, “Expression of Toll-like receptors in human bone marrow mesenchymal stem cells,” Zhongguo Shi Yan Xue Ye Xue Za Zhi, vol. 17, no. 3, pp. 695–699, 2009. View at Google Scholar · View at Scopus
  117. O. DelaRosa and E. Lombardo, “Modulation of adult mesenchymal stem cells activity by toll-like receptors: implications on therapeutic potential,” Mediators of Inflammation, vol. 2010, Article ID 865601, 9 pages, 2010. View at Publisher · View at Google Scholar
  118. G. Raicevic, R. Rouas, M. Najar et al., “Inflammation modifies the pattern and the function of Toll-like receptors expressed by human mesenchymal stromal cells,” Human Immunology, vol. 71, no. 3, pp. 235–244, 2010. View at Publisher · View at Google Scholar · View at Scopus
  119. R. S. Waterman, S. L. Tomchuck, S. L. Henkle, and A. M. Betancourt, “A new mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an immunosuppressive MSC2 phenotype,” PLoS ONE, vol. 5, no. 4, Article ID e10088, 2010. View at Publisher · View at Google Scholar · View at Scopus
  120. X. Han, Q. Yang, L. Lin et al., “Interleukin-17 enhances immunosuppression by mesenchymal stem cells,” Cell Death and Differentiation, vol. 21, no. 11, pp. 1758–1768, 2014. View at Publisher · View at Google Scholar
  121. J. Tian, K. Rui, X. Tang et al., “IL-17 down-regulates the immunosuppressive capacity of olfactory ecto-mesenchymal stem cells in murine collagen-induced arthritis,” Oncotarget, vol. 7, no. 28, pp. 42953–42962, 2016. View at Publisher · View at Google Scholar
  122. R. A. Daynes and D. C. Jones, “Emerging roles of PPARs in inflammation and immunity,” Nature Reviews Immunology, vol. 2, no. 10, pp. 748–759, 2002. View at Publisher · View at Google Scholar · View at Scopus
  123. P. Luz-Crawford, N. Ipseiz, G. Espinosa-Carrasco et al., “PPARβ/δ directs the therapeutic potential of mesenchymal stem cells in arthritis,” Annals of the Rheumatic Diseases, 2016. View at Publisher · View at Google Scholar